Lin Shi

Title: Lin Shi: Innovator in Cell Therapy

Introduction

Lin Shi is a prominent inventor based in Tianjin, China. He has made significant contributions to the field of cell therapy, particularly in the development of modified immune cells. With a total of 3 patents, his work is paving the way for advancements in medical treatments.

Latest Patents

One of Lin Shi's latest patents is titled "Plasmid combination and application thereof in preparing modified immune cells." This patent describes a method for using a four-plasmid system to prepare modified immune effector cells. The process involves forming a lentivirus using four plasmids within 293T cells, extracting the lentivirus, and transfecting immune effector cells to express a chimeric antigen receptor. Additionally, the patent outlines the use of the immune effector cell obtained through this method and a composition containing the immune effector cell.

Another significant patent is "CD19-targeted chimeric antigen receptor and use thereof." This patent details a chimeric antigen receptor that includes an amino acid sequence shown in SEQ ID NO. 1. It encompasses a nucleic acid encoding the chimeric antigen receptor, a vector containing the nucleic acid, and an immune effector cell that comprises the chimeric antigen receptor. The patent also describes a method for preparing the immune effector cell and its various applications.

Career Highlights

Lin Shi is currently employed at Juventas Cell Therapy Ltd., where he continues to innovate in the field of cell therapy. His work is instrumental in developing new therapeutic approaches that leverage modified immune cells to combat diseases.

Collaborations

Lin has collaborated with notable colleagues, including Lulu Lv and Rui Wang. Their combined expertise contributes to the advancement of research and development in cell therapy.

Conclusion

Lin Shi's innovative work in the field of cell therapy, particularly through his patents, showcases his commitment to advancing medical science. His contributions are expected to have a lasting impact on the treatment of various diseases.